The Antimicrobial Drugs Advisory Committee (AMDAC) has scheduled a meeting on Tuesday, 24th January 2023 through an online teleconferencing platform. The committee will discuss NDA 217417, for rezafungin lyophilized powder for injection, submitted by Cidara Therapeutics, Inc., for treatment of candidemia and invasive candidiasis in adults.
Back to All Events
Earlier Event: January 9
Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)
Later Event: January 26
Vaccines and Related Biological Products Advisory Committee (VRBPAC)